{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:49:18Z","timestamp":1767707358257,"version":"3.40.3"},"publisher-location":"Cham","reference-count":85,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319042190"},{"type":"electronic","value":"9783319042206"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-04220-6_8","type":"book-chapter","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T04:28:44Z","timestamp":1396672124000},"page":"237-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enteric Infections"],"prefix":"10.1007","author":[{"given":"Michael","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,6]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archsurg.1990.01410210045006","volume":"125","author":"DS Wade","year":"1990","unstructured":"Wade DS, Douglass H Jr, Nava HR, Piedmonte M (1990) Abdominal pain in neutropenic patients. Arch Surg 125:1119\u20131127","journal-title":"Arch Surg"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1086\/428732","volume":"40","author":"S Reuter","year":"2005","unstructured":"Reuter S, Kern WV, Sigge A et al (2005) Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 40:1087\u20131093","journal-title":"Clin Infect Dis"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/SLA.0b013e3181724fe5","volume":"248","author":"BD Badgwell","year":"2008","unstructured":"Badgwell BD, Cormier JN, Wray CJ et al (2008) Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg 248:104\u2013109","journal-title":"Ann Surg"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s15010-002-1178-2","volume":"30","author":"M Gorschluter","year":"2002","unstructured":"Gorschluter M, Hahn C, Ziske C et al (2002) Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia. Infection 30:22\u201325","journal-title":"Infection"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1086\/514946","volume":"27","author":"L Gomez","year":"1998","unstructured":"Gomez L, Martino R, Rolston KV (1998) Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases. Clin Infect Dis 27:695\u2013699","journal-title":"Clin Infect Dis"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/1097-0142(19920101)69:1<17::AID-CNCR2820690106>3.0.CO;2-X","volume":"69","author":"DS Wade","year":"1992","unstructured":"Wade DS, Nava HR, Douglass HO Jr (1992) Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 69:17\u201323","journal-title":"Cancer"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.2005.00442.x","volume":"75","author":"M Gorschluter","year":"2005","unstructured":"Gorschluter M, Mey U, Strehl J et al (2005) Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 75:1\u201313","journal-title":"Eur J Haematol"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/annonc\/mdl337","volume":"18","author":"DY Aksoy","year":"2007","unstructured":"Aksoy DY, Tanriover MD, Uzun O et al (2007) Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol 18:183\u2013189","journal-title":"Ann Oncol"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.2001.19.3.756","volume":"19","author":"C Cartoni","year":"2001","unstructured":"Cartoni C, Dragoni F, Micozzi A et al (2001) Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol 19:756\u2013761","journal-title":"J Clin Oncol"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1086\/519506","volume":"45","author":"M Picardi","year":"2007","unstructured":"Picardi M, Camera A, Pane F, Rotoli B (2007) Improved management of neutropenic enterocolitis using early ultrasound scan and vigorous medical treatment. Clin Infect Dis 45:403\u2013404","journal-title":"Clin Infect Dis"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/1097-0142(19860201)57:3<616::AID-CNCR2820570337>3.0.CO;2-4","volume":"57","author":"HF Starnes Jr","year":"1986","unstructured":"Starnes HF Jr, Moore FD Jr, Mentzer S, Osteen RT, Steele GD Jr, Wilson RE (1986) Abdominal pain in neutropenic cancer patients. Cancer 57:616\u2013621","journal-title":"Cancer"},{"issue":"4","key":"8_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/514945","volume":"27","author":"S Gorbach","year":"1998","unstructured":"Gorbach S (1998) Editorial response: neutropenic enterocolitis. Clin Infect Dis 27(4):700\u2013701","journal-title":"Clin Infect Dis"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiology.191.1.8134552","volume":"191","author":"GW Boland","year":"1994","unstructured":"Boland GW, Lee MJ, Cats AM, Gaa JA, Saini S, Mueller PR (1994) Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease. Radiology 191:103\u2013106","journal-title":"Radiology"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1086\/339215","volume":"34","author":"WT Hughes","year":"2002","unstructured":"Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730\u2013751","journal-title":"Clin Infect Dis"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infections in adults and children: guidelines by the surgical infectious society and the infectious diseases society of America. Clin Infect Dis 50:133\u2013164","journal-title":"Clin Infect Dis"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2334-6-35","volume":"6","author":"M Gorschluter","year":"2006","unstructured":"Gorschluter M, Mey U, Strehl J et al (2006) Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis 6:35","journal-title":"BMC Infect Dis"},{"key":"8_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa040446","volume":"351","author":"TJ Walsh","year":"2004","unstructured":"Walsh TJ, Teppler H, Donowitz GR et al (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391\u20131402","journal-title":"N Engl J Med"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:2433\u20132441","journal-title":"N Engl J Med"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1086\/322616","volume":"33","author":"M Gorschluter","year":"2001","unstructured":"Gorschluter M, Glasmacher A, Hahn C et al (2001) Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 33:786\u2013791","journal-title":"Clin Infect Dis"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1086\/502600","volume":"26","author":"LC McDonald","year":"2005","unstructured":"McDonald LC (2005) Clostridium difficile: responding to a new threat from an old enemy. Infect Control Hosp Epidemiol 26:672\u2013675","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1086\/523582","volume":"45","author":"ER Dubberke","year":"2007","unstructured":"Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile\u2013associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543\u20131549","journal-title":"Clin Infect Dis"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJM199911253412203","volume":"341","author":"S Johnson","year":"1999","unstructured":"Johnson S, Samore MH, Farrow KA et al (1999) Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 341:1645\u20131651","journal-title":"N Engl J Med"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1086\/502602","volume":"26","author":"TN Palmore","year":"2005","unstructured":"Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA (2005) Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 26:680\u2013684","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1086\/382084","volume":"38","author":"DN Gerding","year":"2004","unstructured":"Gerding DN (2004) Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 38:646\u2013648","journal-title":"Clin Infect Dis"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA et al (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41:1254\u20131260","journal-title":"Clin Infect Dis"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/502539","volume":"26","author":"CA Muto","year":"2005","unstructured":"Muto CA, Pokrywka M, Shutt K et al (2005) A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26:273\u2013280","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/511789","volume":"28","author":"P Biller","year":"2007","unstructured":"Biller P, Shank B, Lind L et al (2007) Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol 28:198\u2013201","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/381551","volume":"38","author":"R Gaynes","year":"2004","unstructured":"Gaynes R, Rimland D, Killum E et al (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38:640\u2013645","journal-title":"Clin Infect Dis"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/jhin.2002.1356","volume":"53","author":"E Blot","year":"2003","unstructured":"Blot E, Escande MC, Besson D et al (2003) Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect 53:187\u2013192","journal-title":"J Hosp Infect"},{"key":"8_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/gyno.1998.5158","volume":"71","author":"A Husain","year":"1998","unstructured":"Husain A, Aptaker L, Spriggs DR, Barakat RR (1998) Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol Oncol 71:104\u2013107","journal-title":"Gynecol Oncol"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1006\/gyno.1996.0158","volume":"61","author":"M Emoto","year":"1996","unstructured":"Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K (1996) Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol 61:369\u2013372","journal-title":"Gynecol Oncol"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/clinids\/17.1.109","volume":"17","author":"A Anand","year":"1993","unstructured":"Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17:109\u2013113","journal-title":"Clin Infect Dis"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMcp011603","volume":"346","author":"JG Bartlett","year":"2002","unstructured":"Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346:334\u2013339","journal-title":"N Engl J Med"},{"issue":"356","key":"8_CR34","first-page":"e7","volume":"119","author":"SS Mohan","year":"2006","unstructured":"Mohan SS, McDermott BP, Parchuri S, Cunha BA (2006) Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 119(356):e7\u2013e8","journal-title":"Am J Med"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1128\/JCM.00684-08","volume":"46","author":"E Aichinger","year":"2008","unstructured":"Aichinger E, Schleck CD, Harmsen WS, Nyre LM, Patel R (2008) Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol 46:3795\u20133797","journal-title":"J Clin Microbiol"},{"key":"8_CR36","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1128\/JCM.44.3.1145-1149.2006","volume":"44","author":"JR Ticehurst","year":"2006","unstructured":"Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC (2006) Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44:1145\u20131149","journal-title":"J Clin Microbiol"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1086\/522185","volume":"45","author":"LR Peterson","year":"2007","unstructured":"Peterson LR, Manson RU, Paule SM et al (2007) Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 45:1152\u20131160","journal-title":"Clin Infect Dis"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/669081","volume":"34","author":"M Wang","year":"2013","unstructured":"Wang M, Evans CT, Rodriguez T, Gerding DN, Johnson S (2013) Clostridium difficile infection (CDI) and limitations of markers for severity in patients with hematologic malignancy. Infect Cont Hosp Epidemiol 34:127\u2013132","journal-title":"Infect Cont Hosp Epidemiol"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1086\/430315","volume":"40","author":"J Pepin","year":"2005","unstructured":"Pepin J, Alary ME, Valiquette L et al (2005) Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40:1591\u20131597","journal-title":"Clin Infect Dis"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1086\/430311","volume":"40","author":"DM Musher","year":"2005","unstructured":"Musher DM, Aslam S, Logan N et al (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40:1586\u20131590","journal-title":"Clin Infect Dis"},{"key":"8_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"FA Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302\u2013307","journal-title":"Clin Infect Dis"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1056\/NEJMra0707500","volume":"359","author":"CP Kelly","year":"2008","unstructured":"Kelly CP, LaMont JT (2008) Clostridium difficile\u2013more difficult than ever. N Engl J Med 359:1932\u20131940","journal-title":"N Engl J Med"},{"key":"8_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y et al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364:422\u2013431","journal-title":"N Engl J Med"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1086\/501126","volume":"42","author":"J Pepin","year":"2006","unstructured":"Pepin J, Routhier S, Gagnon S, Brazeau I (2006) Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42:758\u2013764","journal-title":"Clin Infect Dis"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1086\/318130","volume":"31","author":"CM Surawicz","year":"2000","unstructured":"Surawicz CM, McFarland LV, Greenberg RN et al (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31:1012\u20131017","journal-title":"Clin Infect Dis"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/511870","volume":"44","author":"S Johnson","year":"2007","unstructured":"Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN (2007) Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44:846\u2013848","journal-title":"Clin Infect Dis"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1086\/506351","volume":"43","author":"DM Musher","year":"2006","unstructured":"Musher DM, Logan N, Hamill RJ et al (2006) Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis 43:421\u2013427","journal-title":"Clin Infect Dis"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/367657","volume":"36","author":"J Aas","year":"2003","unstructured":"Aas J, Gessert CE, Bakken JS (2003) Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36:580\u2013585","journal-title":"Clin Infect Dis"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1086\/429916","volume":"40","author":"P Munoz","year":"2005","unstructured":"Munoz P, Bouza E, Cuenca-Estrella M et al (2005) Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis 40:1625\u20131634","journal-title":"Clin Infect Dis"},{"key":"8_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1086\/321883","volume":"33","author":"PM Rechner","year":"2001","unstructured":"Rechner PM, Agger WA, Mruz K, Cogbill TH (2001) Clinical features of clostridial bacteremia: a review from a rural area. Clin Infect Dis 33:349\u2013353","journal-title":"Clin Infect Dis"},{"key":"8_CR51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jinf.2008.06.018","volume":"57","author":"J Leal","year":"2008","unstructured":"Leal J, Gregson DB, Ross T, Church DL, Laupland KB (2008) Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000\u20132006. J Infect 57:198\u2013203","journal-title":"J Infect"},{"key":"8_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1445-1433.2001.02231.x","volume":"71","author":"SS Chew","year":"2001","unstructured":"Chew SS, Lubowski DZ (2001) Clostridium septicum and malignancy. ANZ J Surg 71:647\u2013649","journal-title":"ANZ J Surg"},{"key":"8_CR53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0039-6060(05)80023-6","volume":"118","author":"CM Larson","year":"1995","unstructured":"Larson CM, Bubrick MP, Jacobs DM, West MA (1995) Malignancy, mortality, and medicosurgical management of Clostridium septicum infection. Surgery 118:592\u2013597; discussion 7\u20138","journal-title":"Surgery"},{"key":"8_CR54","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/497143","volume":"41","author":"DL Stevens","year":"2005","unstructured":"Stevens DL, Bisno AL, Chambers HF et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41:1373\u20131406","journal-title":"Clin Infect Dis"},{"key":"8_CR55","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archsurg.139.7.760","volume":"139","author":"JS Gold","year":"2004","unstructured":"Gold JS, Bayar S, Salem RR (2004) Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 139:760\u2013765","journal-title":"Arch Surg"},{"key":"8_CR56","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/1055-9965.EPI-08-0571","volume":"17","author":"AN Burnett-Hartman","year":"2008","unstructured":"Burnett-Hartman AN, Newcomb PA, Potter JD (2008) Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 17:2970\u20132979","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8_CR57","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJM197710132971503","volume":"297","author":"RS Klein","year":"1977","unstructured":"Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, Steigbigel NH (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800\u2013802","journal-title":"N Engl J Med"},{"key":"8_CR58","first-page":"769","volume":"70","author":"GM Mead","year":"1986","unstructured":"Mead GM, Sweetenham JW, Ewins DL, Furlong M, Lowes JA (1986) Intestinal cryptosporidiosis: a complication of cancer treatment. Cancer Treat Rep 70:769\u2013770","journal-title":"Cancer Treat Rep"},{"key":"8_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1128\/CMR.15.1.145-154.2002","volume":"15","author":"PR Hunter","year":"2002","unstructured":"Hunter PR, Nichols G (2002) Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 15:145\u2013154","journal-title":"Clin Microbiol Rev"},{"key":"8_CR60","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1086\/368194","volume":"36","author":"BA Leav","year":"2003","unstructured":"Leav BA, Mackay M, Ward HD (2003) Cryptosporidium\n                        species: new insights and old challenges. Clin Infect Dis 36:903\u2013908","journal-title":"Clin Infect Dis"},{"key":"8_CR61","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/clinids\/13.5.842","volume":"13","author":"G Gentile","year":"1991","unstructured":"Gentile G, Venditti M, Micozzi A et al (1991) Cryptosporidiosis in patients with hematologic malignancies. Rev Infect Dis 13:842\u2013846","journal-title":"Rev Infect Dis"},{"key":"8_CR62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199407213310304","volume":"331","author":"WR Mac Kenzie","year":"1994","unstructured":"Mac Kenzie WR, Hoxie NJ, Proctor ME et al (1994) A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 331:161\u2013167","journal-title":"N Engl J Med"},{"key":"8_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1086\/321008","volume":"184","author":"JF Rossignol","year":"2001","unstructured":"Rossignol JF, Ayoub A, Ayers MS (2001) Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 184:103\u2013106","journal-title":"J Infect Dis"},{"key":"8_CR64","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"LM Fox","year":"2005","unstructured":"Fox LM, Saravolatz LD (2005) Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40:1173\u20131180","journal-title":"Clin Infect Dis"},{"key":"8_CR65","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1086\/322707","volume":"33","author":"AA Siddiqui","year":"2001","unstructured":"Siddiqui AA, Berk SL (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33:1040\u20131047","journal-title":"Clin Infect Dis"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.20120","volume":"100","author":"A Safdar","year":"2004","unstructured":"Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV (2004) Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 100:1531\u20131536","journal-title":"Cancer"},{"key":"8_CR67","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/clinids\/21.3.675","volume":"21","author":"M Nucci","year":"1995","unstructured":"Nucci M, Portugal R, Pulcheri W et al (1995) Strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis 21:675\u2013677","journal-title":"Clin Infect Dis"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10096-005-0070-2","volume":"25","author":"CS Lam","year":"2006","unstructured":"Lam CS, Tong MK, Chan KM, Siu YP (2006) Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis 25:14\u201318","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"8_CR69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00365540701558730","volume":"40","author":"ER Machado","year":"2008","unstructured":"Machado ER, Teixeira EM, Goncalves-Pires Mdo R, Loureiro ZM, Araujo RA, Costa-Cruz JM (2008) Parasitological and immunological diagnosis of Strongyloides\n                         stercoralis in patients with gastrointestinal cancer. Scand J Infect Dis. 40:154\u2013158","journal-title":"Scand J Infect Dis."},{"key":"8_CR70","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/630201","volume":"48","author":"A Roxby","year":"2009","unstructured":"Roxby A, Gottlieb G, Limaye A (2009) Strongyloidiasis in transplant patients. Clin Infect Dis 48:1411\u20131423","journal-title":"Clin Infect Dis"},{"key":"8_CR71","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","volume":"101","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Leisenring W, Riddell SR et al (2003) Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101:407\u2013414","journal-title":"Blood"},{"key":"8_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-112-7-505","volume":"112","author":"EC Reed","year":"1990","unstructured":"Reed EC, Wolford JL, Kopecky KJ et al (1990) Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med 112:505\u2013510","journal-title":"Ann Intern Med"},{"key":"8_CR73","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/00365520510015395","volume":"40","author":"K Nomura","year":"2005","unstructured":"Nomura K, Kamitsuji Y, Kono E et al (2005) Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin\u2019s lymphoma. Scand J Gastroenterol 40:604\u2013606","journal-title":"Scand J Gastroenterol"},{"key":"8_CR74","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1023\/A:1008357619646","volume":"10","author":"J Van den Brande","year":"1999","unstructured":"Van den Brande J, Schrijvers D, Colpaert C, Vermorken JB (1999) Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer. Ann Oncol 10:1369\u20131372","journal-title":"Ann Oncol"},{"key":"8_CR75","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/028418602321028346","volume":"41","author":"T Matthes","year":"2002","unstructured":"Matthes T, Kaiser L, Weber D, Kurt AM, Dietrich PY (2002) Cytomegalovirus colitis\u2013a severe complication after standard chemotherapy. Acta Oncol 41:704\u2013706","journal-title":"Acta Oncol"},{"key":"8_CR76","doi-asserted-by":"crossref","unstructured":"Wade JC (2006) Viral infections in patients with hematological malignancies. Hematology Am Soc Hematol Educ Program 368\u2013374","DOI":"10.1182\/asheducation-2006.1.368"},{"key":"8_CR77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","volume":"118","author":"JM Goodrich","year":"1993","unstructured":"Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 118:173\u2013178","journal-title":"Ann Intern Med"},{"issue":"7","key":"8_CR78","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/10428190701411441","volume":"48","author":"S Aksoy","year":"2007","unstructured":"Aksoy S, Hartuputluoglu H, Kilickap S et al (2007) Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 48(7):1307\u20131312","journal-title":"Leuk Lymphoma"},{"key":"8_CR79","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1086\/504811","volume":"43","author":"S Martin","year":"2006","unstructured":"Martin S, Marty F, Fiumara K (2006) Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 43:16\u201324","journal-title":"Clin Infect Dis"},{"key":"8_CR80","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1128\/JCM.40.5.1581-1586.2002","volume":"40","author":"AM Caliendo","year":"2002","unstructured":"Caliendo AM, George KS, Allega J, Bullotta AC, Gilbane L, Rinaldo CR (2002) Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol 40:1581\u20131586","journal-title":"J Clin Microbiol"},{"key":"8_CR81","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1086\/514572","volume":"26","author":"P Lesprit","year":"1998","unstructured":"Lesprit P, Scieux C, Lemann M, Carbonelle E, Modai J, Molina JM (1998) Use of the cytomegalovirus (CMV) antigenemia assay for the rapid diagnosis of primary CMV infection in hospitalized adults. Clin Infect Dis 26:646\u2013650","journal-title":"Clin Infect Dis"},{"key":"8_CR82","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1086\/323782","volume":"33","author":"A Yoshida","year":"2001","unstructured":"Yoshida A, Hitomi S, Fukui T et al (2001) Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real-time PCR assay. Clin Infect Dis 33:1756\u20131761","journal-title":"Clin Infect Dis"},{"key":"8_CR83","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1128\/jcm.33.11.3064-3067.1995","volume":"33","author":"D Michel","year":"1995","unstructured":"Michel D, Marre E, Hampl W et al (1995) Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples. J Clin Microbiol 33:3064\u20133067","journal-title":"J Clin Microbiol"},{"key":"8_CR84","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1086\/590934","volume":"47","author":"G Torres-Madriz","year":"2008","unstructured":"Torres-Madriz G, Boucher HW (2008) Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 47:702\u2013711","journal-title":"Clin Infect Dis"},{"key":"8_CR85","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1086\/342883","volume":"35","author":"JA Zaia","year":"2002","unstructured":"Zaia JA (2002) Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. Clin Infect Dis 35:999\u20131004","journal-title":"Clin Infect Dis"}],"container-title":["Cancer Treatment and Research","Infectious Complications in Cancer Patients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-04220-6_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T05:39:09Z","timestamp":1674884349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-04220-6_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319042190","9783319042206"],"references-count":85,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-04220-6_8","relation":{},"ISSN":["0927-3042"],"issn-type":[{"type":"print","value":"0927-3042"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"6 April 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}